|
MechanismM2 receptor antagonists [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Mar 1998 |
100 Clinical Results associated with Viatris Pharma Srl
0 Patents (Medical) associated with Viatris Pharma Srl
100 Deals associated with Viatris Pharma Srl
100 Translational Medicine associated with Viatris Pharma Srl